1-2 of 2 results for subject:Pfizer
Librarians' tools
- Search time
- 0.232 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
The ability of bacteria - and other types of pathogen - to develop and propagate resistance to the available therapeutic drugs and medicines, such as antibiotics, used to treat them is a significant and growing threat. Alongside extensive efforts to tackle this threat, as set out in the Government’s five-year...
The ability of bacteria - and other types of pathogen - to develop and propagate resistance to the available therapeutic drugs and medicines, such as antibiotics, used to treat them is a significant and growing threat. Alongside extensive efforts to tackle this threat, as set out in the Government’s five-year...
Departmental Contingent Liability Notification (deployment of the novel oral antiviral drug PF-07321332+ritonavir)
I am making this statement for the benefit of Honourable and Right Honourable members to bring to their attention a contingent liability the Government has agreed to relating to the two contracts signed between Her Majesty’s Government (HMG) and...
Departmental Contingent Liability Notification (deployment of the novel oral antiviral drug PF-07321332+ritonavir)
I am making this statement for the benefit of Honourable and Right Honourable members to bring to their attention a contingent liability the Government has agreed to relating to the two contracts signed between Her Majesty’s Government (HMG) and...